Editorial: Rare hematological malignancies

Editorial: Rare hematological malignancies

Saved in:

Bibliographic Details
Main Author:	Pier Paolo Piccaluga
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-04-01
Series:	Frontiers in Cell and Developmental Biology
Subjects:	rare hematological malignancy peripehral T-cell lymphomas multiple myeloma hematopoietic stem cell transplantation novel agents maintenance therapy
Online Access:	https://www.frontiersin.org/articles/10.3389/fcell.2025.1600063/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma in the Era of New Drugs
by: OV Pirogova, et al.
Published: (2018-04-01)

Case report: pomalidomide as maintenance after salvage autologous stem cell transplantation in a patient with relapsed multiple myeloma
by: S. V. Semochkin, et al.
Published: (2023-12-01)

Preventing pneumococcal infections in patients with hematological malignancies: a review of evidence and recommendations based on modified Delphi consensus
by: Tulika Seth, et al.
Published: (2025-05-01)

The efficacy and safety of plerixafor in hematopoietic stem cell mobilization in patients with Non-Hodgkin lymphoma, multiple myeloma, and Hodgkin lymphoma who failed mobilization with granulocyte-colony-stimulating factor alone: A single-center experience
by: Girish Badarkhe, et al.
Published: (2020-01-01)

The role of pomalidomide in treatment of relapse and refractory multiple myeloma
by: S. V. Voloshin, et al.
Published: (2022-01-01)

Application of mass cytometry to characterize hematopoietic stem cells in apheresis products of patients with hematological malignancies
by: Carlos Agustin Villegas-Valverde, et al.
Published: (2024-12-01)

Therapy efficacy in multiple myeloma patients received autologous stem cells transplantation as first line therapy
by: Ye. I. Darskaya, et al.
Published: (2014-07-01)

Clinical characteristics and prognosis of SARS-CoV-2 infection in children with hematological malignancies: A multicenter, retrospective study in China
by: Weilin Wang, et al.
Published: (2024-11-01)

Cognitive impairments in patients with hematological malignancies prior and after allogeneic hematopoietic stem cells transplantation
by: D. E. Vybornykh, et al.
Published: (2019-07-01)

Microbiota modulation for infectious complications following allogeneic hematopoietic stem cell transplantation in pediatric hematological malignancies
by: Wei Dai, et al.
Published: (2025-03-01)

Cognitive impairment in patients with hematological malignancies at a long-term period after the transplantation of allogeneic hematopoietic stem cells
by: D. E. Vybornykh, et al.
Published: (2020-04-01)

Global, regional, and national economic burden of hematologic malignancies (1990–2021) with projections to 2050
by: Zhexian Li, et al.
Published: (2025-06-01)

Efficacy of palifermin on oral mucositis and acute GVHD after hematopoietic stem cell transplantation (HSCT) in hematology malignancy patients: a meta-analysis of trials
by: Hamid Reza Mozaffari, et al.
Published: (2017-12-01)

CK2 in the spotlight: decoding its role in hematological malignancies and therapeutic applications
by: Zhaoyi Cai, et al.
Published: (2025-05-01)

Editorial: Hematopoietic stress in stem cell homeostasis and disease pathogenesis
by: Jing Ma, et al.
Published: (2025-03-01)

An impact of CMV and HHV-6 reactivation on the course of early period after hematopoietic stem cell transplantation in patients with hematologic malignancies
by: T. V. Antonova, et al.
Published: (2023-01-01)

COEXISTENCE OF RENAL CELL CARCINOMA AND HEMATOLOGICAL MALIGNANCIES
by: Gokhan Sargin, et al.
Published: (2014-08-01)

A dream or reality: Consideration of ‘bloodless’ hematopoietic stem cell transplants for Jehovah’s witness patients
by: Michael MacNeill, et al.
Published: (2025-07-01)

The impact of multiple myeloma drugs treatments on autologous stem cell transplantation in the era of new drugs
by: Xixi Wan, et al.
Published: (2025-02-01)

The use of non-cryopreserved hematopoietic stem cells for autologous transplantation in multiple myeloma patients
by: S. V. Voloshin, et al.
Published: (2022-04-01)

Classification of Conditioning Regimens for Bone Marrow Transplantation: Historical Background and Current Perspectives
by: KN Melkova, et al.
Published: (2017-10-01)

Awareness and Knowledge About Preventive Vaccinations Among Patients with Hematological Malignancies
by: Marta Morawska, et al.
Published: (2025-03-01)

Impact of stem cell source on allogeneic stem cell transplantation outcome in hematological malignancies
by: Stamatović Dragana, et al.
Published: (2011-01-01)

“A.B.C.” of Immunotherapy in Hematological Malignancies…Promise and Perils
by: Jyoti Bajpai, et al.
Published: (2024-04-01)

Bone marrow MRI after autologous transplantation and the effect of residual tumor on progression-free survival of multiple myeloma patients
by: M. V. Solovev, et al.
Published: (2019-01-01)

Haploidentical Hematopoietic Stem Cell Transplantation for Relapsed/Refractory Extramedullary Multiple Myeloma: A Conditioning Regimen Combining Selinexor and Helical Tomotherapy—A Case Report and Literature Review
by: Chen B, et al.
Published: (2025-04-01)

Current advances in the role of classical non‐homologous end joining in hematologic malignancies
by: Pengcheng Liu, et al.
Published: (2025-06-01)

Any closer to successful therapy of multiple myeloma? CAR-T cell is a good reason for optimism
by: Faroogh Marofi, et al.
Published: (2021-03-01)

Association of myeloid-derived suppressor cells with hematopoietic recovery after high-dose chemotherapy in multiple myeloma
by: V. S. Anmut, et al.
Published: (2023-06-01)

The role of non-malignant B cells in malignant hematologic diseases
by: Daquan Gao
Published: (2025-12-01)

Experience with the Use of Thio/Mel Conditioning Regimen Prior to Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma
by: SV Gritsaev, et al.
Published: (2019-05-01)

Certain Aspects of Autologous Hematopoietic Stem Cell Transplantation in Patients with Multiple Myeloma
by: SV Gritsaev, et al.
Published: (2017-01-01)

Autologous stem cell transplantation in newly diagnosed multiple myeloma patients with severe renal failure requiring hemodialysis. A single-center experience
by: Yu. I. Kliuchagina, et al.
Published: (2024-09-01)

THE ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN FOLLICULAR LYMPHOMA IN THE NEW DRUGS ERA.
by: Francesco Maura, et al.
Published: (2016-09-01)

Recombinant human thrombopoietin does not promote platelet engraftment in newly diagnosed multiple myeloma patients following autologous stem cell transplantation
by: Ruiqi Wang, et al.
Published: (2025-02-01)

Autologous Hematopoietic Cell Transplant as an Effective Treatment Modality for Systemic Sclerosis and Multiple Myeloma
by: Memon H, et al.
Published: (2025-01-01)

Factors Associated with Efficient Harvesting and Engraftment of Auto-Transplants in Multiple Myeloma Patients
by: II Kostroma, et al.
Published: (2018-12-01)

Mindfulness vs. sleep education during autologous hematopoietic cell transplantation for multiple myeloma: Feasibility of a randomized controlled pilot study
by: Elisabeth C. Henley, et al.
Published: (2025-10-01)

Clinical benefit loss in myeloma patients declining autologous stem cell transplantation: a real-world study
by: Yue Wang, et al.
Published: (2025-04-01)

Harnessing the power of exosomes for diagnosis, prognosis, and treatment of hematological malignancies
by: Amirata Mohseni, et al.
Published: (2025-01-01)